Characterization of the Immediate and Delayed Biomechanical Response to UV-A Crosslinking of Human Corneas

Cornea. 2023 Sep 1;42(9):1163-1171. doi: 10.1097/ICO.0000000000003336. Epub 2023 Jun 19.

Abstract

Purpose: Keratoconus leads to visual deterioration due to irregular astigmatism and corneal thinning. Riboflavin-based corneal UV-A crosslinking (CXL) induces novel intramolecular and intermolecular links resulting in corneal tissue stiffening, thereby halting disease progression. The purpose of this study was to analyze the immediate and delayed biomechanical responses of human donor corneas to CXL.

Methods: CXL was performed according to the Dresden protocol to corneas not suitable for transplantation. Biomechanical properties were subsequently monitored by measuring the Young modulus using nanoindentation. The immediate tissue response was determined after 0, 1, 15, and 30 minutes of irradiation. Delayed biomechanical effects were investigated with follow-up measurements immediately and 1, 3, and 7 days after CXL.

Results: Young's modulus indicated a linear trend in direct response to increasing irradiation times (mean values: total 61.31 kPa [SD 25.53], 0 minutes 48.82 kPa [SD 19.73], 1 minute 53.44 kPa [SD 25.95], 15 minutes 63.56 kPa [SD 20.99], and 30 minutes 76.76 kPa [SD 24.92]). The linear mixed model for the elastic response of corneal tissue was 49.82 kPa + (0.91 kPa/min × time [minutes]); P < 0.001. The follow-up measurements showed no significant delayed changes in the Young modulus (mean values: total 55,28 kPa [SD 15.95], immediately after CXL 56,83 kPa [SD 18.74], day 1 50.28 kPa [SD 14.15], day 3 57.08 kPa [SD 14.98], and day 7 56.83 kPa [SD 15.07]).

Conclusions: This study suggests a linear increase of corneal Young modulus as a function of CXL timing. No significant short-term delayed biomechanical changes posttreatment were observed.

MeSH terms

  • Biomechanical Phenomena
  • Cornea
  • Cross-Linking Reagents / pharmacology
  • Elastic Modulus
  • Humans
  • Keratoconus* / drug therapy
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use
  • Riboflavin / pharmacology
  • Riboflavin / therapeutic use
  • Ultraviolet Rays*

Substances

  • Cross-Linking Reagents
  • Riboflavin
  • Photosensitizing Agents